DK0594570T3 - Colestyramine-containing micro tablets as lipid-lowering agent - Google Patents

Colestyramine-containing micro tablets as lipid-lowering agent

Info

Publication number
DK0594570T3
DK0594570T3 DK90913811.7T DK90913811T DK0594570T3 DK 0594570 T3 DK0594570 T3 DK 0594570T3 DK 90913811 T DK90913811 T DK 90913811T DK 0594570 T3 DK0594570 T3 DK 0594570T3
Authority
DK
Denmark
Prior art keywords
colestyramine
lipid
lowering agent
containing micro
micro tablets
Prior art date
Application number
DK90913811.7T
Other languages
Danish (da)
Inventor
Thomas Moest
Erwin Spiegel
Original Assignee
Knoll Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE3930168A external-priority patent/DE3930168A1/en
Priority claimed from DE19893930206 external-priority patent/DE3930206A1/en
Application filed by Knoll Ag filed Critical Knoll Ag
Application granted granted Critical
Publication of DK0594570T3 publication Critical patent/DK0594570T3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics

Abstract

Preparations containing colestyramine for reducing lipid levels.
DK90913811.7T 1989-09-09 1990-09-07 Colestyramine-containing micro tablets as lipid-lowering agent DK0594570T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3930168A DE3930168A1 (en) 1989-09-09 1989-09-09 Pharmaceutical compsn. contg. colestyramine to reduce lipid - in micro:tablet form levels without unpleasant taste
DE19893930206 DE3930206A1 (en) 1989-09-09 1989-09-09 Hypolipaemic pharmaceutical prods. - comprising combination of cholestyramine and drug of vibrate type

Publications (1)

Publication Number Publication Date
DK0594570T3 true DK0594570T3 (en) 1995-09-11

Family

ID=25884990

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90913811.7T DK0594570T3 (en) 1989-09-09 1990-09-07 Colestyramine-containing micro tablets as lipid-lowering agent

Country Status (10)

Country Link
EP (1) EP0594570B1 (en)
JP (1) JPH05500213A (en)
KR (1) KR920703071A (en)
AT (1) ATE125448T1 (en)
AU (1) AU638493B2 (en)
CA (1) CA2065151A1 (en)
DE (1) DE59009451D1 (en)
DK (1) DK0594570T3 (en)
IL (1) IL95574A (en)
WO (1) WO1991003249A1 (en)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3023102T (en) 2010-11-08 2018-09-25 Albireo Ab Ibat inhibitors for the treatment of liver diseases
CN106659726A (en) 2014-06-25 2017-05-10 Ea制药株式会社 Solid preparation, and method for preventing or reducing discoloration thereof
EP3012252A1 (en) 2014-10-24 2016-04-27 Ferring BV Crystal modifications of elobixibat
US10441605B2 (en) 2016-02-09 2019-10-15 Albireo Ab Oral cholestyramine formulation and use thereof
US10441604B2 (en) 2016-02-09 2019-10-15 Albireo Ab Cholestyramine pellets and methods for preparation thereof
EP3413878B1 (en) * 2016-02-09 2021-04-14 Albireo AB Oral cholestyramine formulation and use thereof
CN108601739B (en) * 2016-02-09 2022-01-04 阿尔比里奥公司 Cholestyramine pill and preparation method thereof
ES2874669T3 (en) * 2016-02-09 2021-11-05 Albireo Ab Oral formulation of cholestyramine and its use
US10786529B2 (en) * 2016-02-09 2020-09-29 Albireo Ab Oral cholestyramine formulation and use thereof
JP2020530448A (en) 2017-08-09 2020-10-22 アルビレオ・アクチボラグ Cholestyramine granules, oral cholestyramine preparations, and their use
EP3664782A1 (en) * 2017-08-09 2020-06-17 Albireo AB Cholestyramine pellets, oral cholestyramine formulations and use thereof
WO2019234077A1 (en) 2018-06-05 2019-12-12 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
US10793534B2 (en) 2018-06-05 2020-10-06 Albireo Ab Benzothia(di)azepine compounds and their use as bile acid modulators
SG11202012151XA (en) 2018-06-20 2021-01-28 Albireo Ab Crystal modifications of odevixibat
US11801226B2 (en) 2018-06-20 2023-10-31 Albireo Ab Pharmaceutical formulation of odevixibat
US10722457B2 (en) 2018-08-09 2020-07-28 Albireo Ab Oral cholestyramine formulation and use thereof
US11007142B2 (en) 2018-08-09 2021-05-18 Albireo Ab Oral cholestyramine formulation and use thereof
US11549878B2 (en) 2018-08-09 2023-01-10 Albireo Ab In vitro method for determining the adsorbing capacity of an insoluble adsorbant
US10941127B2 (en) 2019-02-06 2021-03-09 Albireo Ab Benzothiadiazepine compounds and their use as bile acid modulators
US10975045B2 (en) 2019-02-06 2021-04-13 Aibireo AB Benzothiazepine compounds and their use as bile acid modulators
JP2023504643A (en) 2019-12-04 2023-02-06 アルビレオ・アクチボラグ Benzothia(di)azepine compounds and their use as bile acid modulators
US11014898B1 (en) 2020-12-04 2021-05-25 Albireo Ab Benzothiazepine compounds and their use as bile acid modulators
BR112022010505A2 (en) 2019-12-04 2022-09-06 Albireo Ab BENZOTHYA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILIARY ACID MODULATION
JP2023504644A (en) 2019-12-04 2023-02-06 アルビレオ・アクチボラグ Benzothiadiazepine compounds and their use as bile acid modulators
CN114786772B (en) 2019-12-04 2024-04-09 阿尔比里奥公司 Benzothiazepine compounds and their use as bile acid modulators
JP2023537285A (en) 2020-08-03 2023-08-31 アルビレオ・アクチボラグ Benzothia(di)azepine compounds and their use as bile acid modulators
KR20230106651A (en) 2020-11-12 2023-07-13 알비레오 에이비 Odevixivat for the treatment of progressive familial intrahepatic cholestasis (PFIC)
JP2024500309A (en) 2020-12-04 2024-01-09 アルビレオ エービー Benzothia(di)azepine compounds and their use as bile acid modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1348642A (en) * 1970-10-15 1974-03-20 Howard A N Hypocholesterolaemic compositions
GB1566609A (en) 1977-03-10 1980-05-08 Reckitt & Colmann Prod Ltd Pharmaceutical compositions containing cholestyramine and alginic acid
DE3572440D1 (en) 1984-06-19 1989-09-28 Basf Ag Gastro-resistant cylindrical pancreatine-microtablets
US4814354A (en) * 1986-09-26 1989-03-21 Warner-Lambert Company Lipid regulating agents
ZA876640B (en) 1986-09-26 1988-03-08 Warner-Lambert Company Treated lipid regulator
CA1313135C (en) * 1987-02-09 1993-01-26 The Dow Chemical Company Cholestyramine composition and process for its preparation
EP0323666B1 (en) * 1987-12-29 1992-03-25 The Procter & Gamble Company Mixed compositions for treating hypercholesterolemia
DE3808191C2 (en) 1988-03-11 1998-08-06 Astra Chem Gmbh Pharmaceutical composition containing colestyramine
US4931280A (en) 1988-06-13 1990-06-05 Basf K & F Corporation Edible, baked compositions containing cholestyramine

Also Published As

Publication number Publication date
KR920703071A (en) 1992-12-17
WO1991003249A1 (en) 1991-03-21
CA2065151A1 (en) 1991-03-10
AU6405790A (en) 1991-04-08
ATE125448T1 (en) 1995-08-15
AU638493B2 (en) 1993-07-01
EP0594570A1 (en) 1994-05-04
JPH05500213A (en) 1993-01-21
DE59009451D1 (en) 1995-08-31
IL95574A (en) 1994-11-11
IL95574A0 (en) 1991-06-30
EP0594570B1 (en) 1995-07-26

Similar Documents

Publication Publication Date Title
DK0594570T3 (en) Colestyramine-containing micro tablets as lipid-lowering agent
FI924553A0 (en) THIOFENSULPHONAMIDER ANVAENDBARA SOM COLOLHYDRASINHIBITORER
NO900227D0 (en) EXTRADABLE ELASTIC GEL FOR USE OF THERAPEUTIC AGENT.
FI921606A0 (en) MICROPEROXIDE INNEHAOLLANDE HEMOPEPTID SOM ACTIVE COMPONENT.
NL960002I1 (en) New taxol derivatives, processes for their preparation and pharmaceutical preparations containing them.
ES2126766T3 (en) TROPYL 7-AZAINDOL-3-ILCARBOXIAMIDES AS ANTI-TUSSIVE AGENT.
AU7619291A (en) Use of baclofen for obtaining medicaments for the treatment of angina pectoris
FI905933A0 (en) MULTILAGER FILM SOM HAEFTAR VID KOETT.
MX9102580A (en) NEW BENZODIACEPINONAS, PROCEDURE FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION THAT CONTAINS THEM.
FI900762A0 (en) TRIS-HYDROXIMETYLALKANESTRAR SOM FETTIMITATIONER MED LAOG KALORIHALT.
FI892214A0 (en) KOPPARLEGERING FOER ANVAENDNING SOM MOTSTAONDSSVETSELEKTROD.
NO960272D0 (en) Oxathiolanes, processes for their preparation and pharmaceutical compositions containing the same
FI884545A0 (en) PHARMACEUTICAL COMPOSITION, SOM INNEHAOLLER AVSVAELLANDE PIPERIDINOALKANOLFOERENINGAR.
DE69019600D1 (en) Plasma display device.
DK0577745T3 (en) Bis-naphthalimides containing amide and thioamide compounds as anticancer agents.
DK234489A (en) PHARMACEUTICAL PREPARATION CONTAINING AN IMMUNOSUPPRESSIVE AGENT
NO901672D0 (en) MIXTURE FOR USE AS A SURFACTIVE AGENT IN DETERGENTS
NO901169L (en) AZOL-1 ALKANAMIDES AS ANTI-ARTHRITMIC AGENTS AND PREPARATION thereof.
FI894072A (en) POLYPEPTIDER ANVAENDBARA SOM VACCIN.
FI883453A0 (en) BICYCLOSE STANDARDS FOR SUSTAINABLE FRAMSTERING.
FI903885A0 (en) NY ORAL PHARMACEUTICAL DOSERINGSFORM SOM FOERBAETTRAR BIOTILLGAENGLIGHETEN.
FI903111A0 (en) BIS (BENZYLPYRROLIDINE) DERIVAT SOM DOPAMINANTAGONISTER.
DE69017188T2 (en) Projection display device.
NO901200D0 (en) AZOL-1 ALKANAMIDES AS ANTI-ARTHRITMIC AGENTS AND PREPARATION thereof.
FR2654835B1 (en) MICRO-COLUMNS FOR CHROMATOGRAPHY.